(ARGX) Argen-X - Performance 56.4% in 12m
Compare ARGX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
89.23%
#3 in Group
Rel. Strength
91.55%
#675 in Universe
Total Return 12m
56.43%
#26 in Group
Total Return 5y
322.93%
#6 in Group
P/E 47.8
81th Percentile in Group
P/E Forward 87.7
92th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.24%
79th Percentile in Group
12m Total Return: ARGX (56.4%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ARGX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARGX
Total Return (including Dividends) | ARGX | XBI | S&P 500 |
---|---|---|---|
1 Month | 4.49% | 5.55% | -0.45% |
3 Months | -10.58% | -9.75% | -6.29% |
12 Months | 56.43% | -5.39% | 13.04% |
5 Years | 322.93% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | ARGX | XBI | S&P 500 |
1 Month | 25.3% | 70% | 47.5% |
3 Months | -86.7% | -88.1% | -87.3% |
12 Months | 82.5% | -44.4% | 54.3% |
5 Years | 91.0% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #110 | -1.55% | 5.70% |
3 Month | #76 | -1.45% | -3.90% |
12 Month | #25 | 66.4% | 40.7% |
5 Years | #5 | 385% | 101% |
FAQs
Does ARGX Argen-X outperforms the market?
Yes,
over the last 12 months ARGX made 56.43%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ARGX made -10.58%, while XBI made -9.75%.
Over the last 3 months ARGX made -10.58%, while XBI made -9.75%.
Performance Comparison ARGX vs Indeces and Sectors
ARGX vs. Indices ARGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.70% | 4.94% | 4.55% | 43.4% |
US NASDAQ 100 | QQQ | 3.78% | 2.59% | 3.84% | 41.5% |
US Dow Jones Industrial 30 | DIA | 5.24% | 7.34% | 5.31% | 47.2% |
German DAX 40 | DAX | 5.06% | 4.71% | -13.5% | 31.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.35% | 7.70% | 8.25% | 51.5% |
Hongkong Hang Seng | HSI | 5.10% | 6.01% | 4.02% | 43.5% |
India NIFTY 50 | INDA | 7.22% | -0.39% | 4.67% | 53.5% |
Brasil Bovespa | EWZ | 6.33% | 1.66% | -1.15% | 63.2% |
ARGX vs. Sectors ARGX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 4.55% | 5.09% | -1.43% | 33.0% |
Consumer Discretionary | XLY | 4.67% | 5.08% | 3.38% | 41.8% |
Consumer Staples | XLP | 6.76% | 5.31% | 0.45% | 45.5% |
Energy | XLE | 8.96% | 18.5% | 9.69% | 65.8% |
Financial | XLF | 5.81% | 6.50% | -2.38% | 33.8% |
Health Care | XLV | 7.40% | 9.16% | 9.71% | 57.7% |
Industrial | XLI | 4.38% | 4.19% | 3.51% | 45.7% |
Materials | XLB | 6.51% | 7.71% | 12.4% | 60.9% |
Real Estate | XLRE | 4.81% | 5.59% | 4.39% | 38.1% |
Technology | XLK | 3.14% | 2.06% | 7.50% | 46.0% |
Utilities | XLU | 5.98% | 4.39% | 0.13% | 35.6% |
Aerospace & Defense | XAR | 3.67% | -2.49% | -9.33% | 29.0% |
Biotech | XBI | 4.86% | -1.06% | 19.9% | 61.8% |
Homebuilder | XHB | 5.97% | 6.57% | 19.5% | 62.6% |
Retail | XRT | 5.94% | 5.65% | 10.5% | 57.9% |